147 related articles for article (PubMed ID: 38047214)
21. Interobserver variability in clinical target volume delineation for primary mediastinal B-cell lymphoma.
Piva C; Genovesi D; Filippi AR; Balducci M; Barra S; Buglione M; Busetto M; Ciammella P; Franzone P; De Sanctis V; Simontacchi G; Fusella M; Ricardi U;
Pract Radiat Oncol; 2015; 5(6):383-9. PubMed ID: 26547826
[TBL] [Abstract][Full Text] [Related]
22. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
[TBL] [Abstract][Full Text] [Related]
23. Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-Prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial.
Harmon G; Chan D; Lee B; Miller C; Gorbonos A; Gupta G; Quek M; Woods M; Savir-Baruch B; Harkenrider MM; Solanki AA
Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):1195-1203. PubMed ID: 34015368
[TBL] [Abstract][Full Text] [Related]
24. An Analysis of the Distribution of PSMA PET/CT-Positive Lymph Nodes and Their Coverage by Different Elective Nodal Radiation Volumes in Postoperative Prostate Cancer Patients.
Trapp C; Oliinyk D; Rogowski P; von Bestenbostel R; Ganswindt U; Li M; Eze C; Bartenstein P; Beyer L; Ilhan H; Sheikh G; Unterrainer L; Stief C; Westhofen T; Kunz WG; Unterrainer M; Belka C; Schmidt-Hegemann NS
J Nucl Med; 2023 Jun; 64(6):918-923. PubMed ID: 36732055
[TBL] [Abstract][Full Text] [Related]
25. The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases.
Zilli T; Dirix P; Heikkilä R; Liefhooghe N; Siva S; Gomez-Iturriaga A; Everaerts W; Otte F; Shelan M; Mercier C; Achard V; Thon K; Stellamans K; Moon D; Conde-Moreno A; Papachristofilou A; Scorsetti M; Gückenberger M; Ameye F; Zapatero A; Van De Voorde L; López Campos F; Couñago F; Jaccard M; Spiessens A; Semac I; Vanhoutte F; Goetghebeur E; Reynders D; Ost P
Eur Urol Focus; 2021 Mar; 7(2):241-244. PubMed ID: 33386290
[TBL] [Abstract][Full Text] [Related]
26. Incidental Dose to Pelvic Nodal Regions in Prostate-Only Radiotherapy.
Murthy V; Lewis S; Sawant M; Paul SN; Mahantshetty U; Shrivastava SK
Technol Cancer Res Treat; 2017 Apr; 16(2):211-217. PubMed ID: 27492806
[TBL] [Abstract][Full Text] [Related]
27. Contouring of emerging organs-at-risk (OARS) of the female pelvis and interobserver variability: A study by the Italian association of radiotherapy and clinical oncology (AIRO).
Augurio A; Macchia G; Caravatta L; Lucarelli M; Di Gugliemo F; Vinciguerra A; Seccia B; De Sanctis V; Autorino R; Delle Curti C; Meregalli S; Perrucci E; Raspanti D; Cerrotta A
Clin Transl Radiat Oncol; 2023 Nov; 43():100688. PubMed ID: 37854671
[TBL] [Abstract][Full Text] [Related]
28. Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China.
Chang X; Deng W; Wang X; Zhou Z; Yang J; Guo W; Liu M; Qi X; Li L; Zhang K; Zhang M; Shi Y; Liu K; Zhao Y; Wang H; Yu Z; Zhang J; Wang L; Qiao X; Han C; Zhu S; Zhang R; Chen J; Hu C; Zhang F; Hou X; Pang Q; Zhang W; Li G; Lin H; Sun X; Ge X; Li C; Ge H; Li D; Wang Y; Lu N; Gao X; Qin S; Tian Y; Xiao Z
Radiat Oncol; 2021 Jun; 16(1):102. PubMed ID: 34107984
[TBL] [Abstract][Full Text] [Related]
29. PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases.
Beaton L; Nica L; Tyldesley S; Sek K; Ayre G; Aparicio M; Gondara L; Speers C; Nichol A
Radiat Oncol; 2020 Jun; 15(1):136. PubMed ID: 32487183
[TBL] [Abstract][Full Text] [Related]
30. Variability of radiotherapy volume delineation: PSMA PET/MRI and MRI based clinical target volume and lymph node target volume for high-risk prostate cancer.
Liu LL; Zhu LL; Lu ZG; Sun JD; Zhao J; Wang HF; Xiang ZL
Cancer Imaging; 2023 Jan; 23(1):1. PubMed ID: 36600283
[TBL] [Abstract][Full Text] [Related]
31. Haute Couture or Ready-to-Wear? Tailored Pelvic Radiotherapy for Prostate Cancer Based on Individualized Sentinel Lymph Node Detection.
Michaud AV; Samain B; Ferrer L; Fleury V; Doré M; Colombié M; Dupuy C; Rio E; Guimas V; Rousseau T; Le Thiec M; Delpon G; Rousseau C; Supiot S
Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32290356
[TBL] [Abstract][Full Text] [Related]
32. Prostate-specific membrane antigen positron emission tomography detected local failure after post-prostatectomy radiation therapy: Low rates of out-of-field recurrence validates current Australian prostate bed contouring guidelines.
Shakespeare TP; Yap SZL; Hsieh M; Tahir ARM; Armstrong S
J Med Imaging Radiat Oncol; 2023 Sep; 67(6):662-667. PubMed ID: 37401187
[TBL] [Abstract][Full Text] [Related]
33. Variation in the definition of clinical target volumes for pelvic nodal conformal radiation therapy for prostate cancer.
Lawton CA; Michalski J; El-Naqa I; Kuban D; Lee WR; Rosenthal SA; Zietman A; Sandler H; Shipley W; Ritter M; Valicenti R; Catton C; Roach M; Pisansky TM; Seider M
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):377-82. PubMed ID: 18947941
[TBL] [Abstract][Full Text] [Related]
34. Role of 68-Ga-PSMA-PET/CT in pelvic radiotherapy field definitions for lymph node coverage in prostate cancer patients.
Onal C; Ozyigit G; Guler OC; Hurmuz P; Torun N; Tuncel M; Dolek Y; Yedekci Y; Oymak E; Tilki B; Akyol F
Radiother Oncol; 2020 Oct; 151():222-227. PubMed ID: 32861704
[TBL] [Abstract][Full Text] [Related]
35. Interobserver variability in delineation of target volumes in head and neck cancer.
van der Veen J; Gulyban A; Nuyts S
Radiother Oncol; 2019 Aug; 137():9-15. PubMed ID: 31048235
[TBL] [Abstract][Full Text] [Related]
36. Improving the accuracy and consistency of clinical target volume delineation for rectal cancer by an education program.
Zhang YZ; Zhu XG; Song MX; Yao KN; Li S; Geng JH; Wang HZ; Li YH; Cai Y; Wang WH
World J Gastrointest Oncol; 2022 May; 14(5):1027-1036. PubMed ID: 35646284
[TBL] [Abstract][Full Text] [Related]
37. Salvage radiotherapy in patients affected by oligorecurrent pelvic nodal prostate cancer.
Ingrosso G; Mariucci C; Tenti MV; Bini V; Alì E; Saldi S; Palumbo I; Bellavita R; Aristei C
Clin Transl Oncol; 2020 Dec; 22(12):2236-2243. PubMed ID: 32418156
[TBL] [Abstract][Full Text] [Related]
38. Inguinal nodal clinical target volume delineation based on analysis of anatomical locations of normal and metastatic lymph nodes in pelvic malignant tumors.
Chang Y; Li G; Yang Z; Han G; Li X; Zhao Y; Yang Q; Wu G; Yang K; Zhao Y
Radiother Oncol; 2023 Jun; 183():109634. PubMed ID: 36963443
[TBL] [Abstract][Full Text] [Related]
39. Deep learning for elective neck delineation: More consistent and time efficient.
van der Veen J; Willems S; Bollen H; Maes F; Nuyts S
Radiother Oncol; 2020 Dec; 153():180-188. PubMed ID: 33065182
[TBL] [Abstract][Full Text] [Related]
40. Comparison of
Walacides D; Meier A; Knöchelmann AC; Meinecke D; Derlin T; Bengel FM; Ross TL; Wester HJ; Derlin K; Kuczyk MA; von Klot CAJ; Christiansen H; Henkenberens C
Strahlenther Onkol; 2019 May; 195(5):420-429. PubMed ID: 30610354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
